Kaplan-Meier estimate of PFS according to MRD status at C4D15. FL cohort (A), DLBCL cohort (B), and DLBCL 160 mg and 320 mg once-weekly cohorts (C) in the C4D15 biomarker population, with PFS estimated from C4D15 response assessment date. Median PFS is presented in months. NE, not estimable.